Quick Answer
BALCHEM CORP reported Operating Income Loss of $209.33 million for the year ending 2025.
- BALCHEM CORP showed an increase of +14.4% in Operating Income Loss from 2024 to 2025.
- This data is from BALCHEM CORP's annual report (Form 10-K), filed with the SEC on February 20, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2010: $12.44 million | Q3 2010: $13.02 million | Q1 2011: $13.30 million | Q2 2011: $14.06 million | Q3 2011: $15.18 million | Q1 2012: $13.68 million | Q2 2012: $14.83 million | Q3 2012: $16.24 million | Q1 2013: $15.87 million | Q2 2013: $16.62 million | Q3 2013: $16.98 million | Q1 2014: $13.36 million | Q2 2014: $16.51 million | Q3 2014: $25.28 million | Q1 2015: $25.04 million | Q2 2015: $23.77 million | Q3 2015: $22.92 million | Q1 2016: $19.97 million | Q2 2016: $23.33 million | Q3 2016: $22.95 million | Q1 2017: $22.70 million | Q2 2017: $24.83 million | Q3 2017: $23.06 million | Q1 2018: $27.24 million | Q2 2018: $27.10 million | Q3 2018: $25.52 million | Q1 2019: $26.48 million | Q2 2019: $26.40 million | Q3 2019: $26.03 million | Q1 2020: $26.28 million | Q2 2020: $26.92 million | Q3 2020: $29.03 million | Q1 2021: $30.58 million | Q2 2021: $30.59 million | Q3 2021: $32.51 million | Q1 2022: $38.34 million | Q2 2022: $39.92 million | Q3 2022: $33.63 million | Q1 2023: $34.41 million | Q2 2023: $42.84 million | Q3 2023: $43.61 million | Q1 2024: $41.68 million | Q2 2024: $45.80 million | Q3 2024: $47.99 million | Q1 2025: $51.02 million | Q2 2025: $51.44 million | Q3 2025: $54.58 million.
- Over the full 17 years of available data (2009 to 2025), BALCHEM CORP's Operating Income Loss has grown by 414.8%.
- Historical annual values: Fiscal year 2025: $209.33 million | Fiscal year 2024: $182.91 million | Fiscal year 2023: $159.19 million | Fiscal year 2022: $145.19 million | Fiscal year 2021: $127.50 million | Fiscal year 2020: $111.15 million | Fiscal year 2019: $102.55 million | Fiscal year 2018: $107.10 million | Fiscal year 2017: $96.90 million | Fiscal year 2016: $90.84 million | Fiscal year 2015: $93.96 million | Fiscal year 2014: $82.14 million | Fiscal year 2013: $65.60 million | Fiscal year 2012: $59.78 million | Fiscal year 2011: $56.23 million | Fiscal year 2010: $49.77 million | Fiscal year 2009: $40.66 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: